Loading...
Outcomes of Vismodegib for Periocular Locally Advanced Basal Cell Carcinoma From an Open-label Trial
IMPORTANCE: The outcomes of vismodegib treatment in a relatively large cohort of study participants with periocular locally advanced basal cell carcinoma (POLA-BCC) may guide physicians when considering this treatment. OBJECTIVE: To report the outcomes of vismodegib treatment in patients with POLA-B...
Na minha lista:
| Udgivet i: | JAMA Ophthalmol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7226292/ https://ncbi.nlm.nih.gov/pubmed/32407451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2020.1539 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|